(VLTO) Veralto - Overview
Sector: Industrials | Industry: Pollution & Treatment Controls | Exchange: NYSE (USA) | Market Cap: 21.085m USD | Total Return: -15.5% in 12m
Water Analytics, Water Treatment, Marking, Packaging Software, Color Management
Total Rating 54
Safety 72
Buy Signal -0.41
Pollution & Treatment Controls
Industry Rotation: -3.3
Industry Rotation: -3.3
Market Cap:
21.1B
Avg Turnover: 174M
Avg Turnover: 174M
Risk 3d forecast
Volatility20.9%
VaR 5th Pctl3.58%
VaR vs Median3.99%
Reward TTM
Sharpe Ratio-0.95
Rel. Str. IBD15.6
Rel. Str. Peer Group30
Character TTM
Beta0.539
Beta Downside0.539
Hurst Exponent0.503
Drawdowns 3y
Max DD24.79%
CAGR/Max DD0.10
CAGR/Mean DD0.26
EPS (Earnings per Share)
EPS CAGR: 9.74%
EPS Trend: 93.5%
EPS Trend: 93.5%
Last SUE: 2.44
Qual. Beats: 3
Qual. Beats: 3
Revenue
Rev. CAGR: 3.92%
Rev. Trend: 95.2%
Rev. Trend: 95.2%
Last SUE: 1.17
Qual. Beats: 1
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: VLTO Veralto
Veralto Corporation is a global industrial technology firm operating through two primary segments: Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment focuses on precision instrumentation and chemical treatment for municipal and industrial water systems, utilizing brands like Hach and ChemTreat. The PQI segment provides marking, coding, and color management solutions for consumer goods packaging through established brands including Videojet and Pantone.
The company operates a highly recurring business model, as the majority of its revenue is derived from consumables and services required to maintain its installed base of sensors and printers. In the water sector, Veralto benefits from stringent environmental regulations that necessitate continuous monitoring and precise chemical dosing. For deeper insights into these recurring revenue streams, investors can consult ValueRay for further data.
Spun off from Danaher Corporation in 2023, Veralto serves diverse end-markets including food and beverage, pharmaceutical, and municipal utilities. Its competitive position is supported by high switching costs associated with integrating its software and specialized hardware into complex manufacturing and treatment workflows.
- Tightening global water quality regulations drive demand for municipal treatment technologies
- Recurring revenue from consumables and service contracts stabilizes long-term cash flows
- Industrial manufacturing output fluctuations impact marking and coding equipment sales
- Environmental compliance standards accelerate adoption of advanced water analytics software
- Margin expansion depends on successful operational independence following spin-off from Danaher
Piotroski VR‑10 (Strict)
7.5
| Net Income: 969.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 0.67 > 1.0 |
| NWC/Revenue: 17.16% < 20% (prev 26.29%; Δ -9.13% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.10b > Net Income 969.0m |
| Net Debt (1.23b) to EBITDA (1.37b): 0.90 < 3 |
| Current Ratio: 1.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (249.2m) vs 12m ago -0.36% < -2% |
| Gross Margin: 59.86% > 18% (prev 0.60%; Δ 5.93k% > 0.5%) |
| Asset Turnover: 78.23% > 50% (prev 79.44%; Δ -1.21% > 0%) |
| Interest Coverage Ratio: 13.96 > 6 (EBITDA TTM 1.37b / Interest Expense TTM 93.0m) |
Altman Z''
3.11
| A: 0.13 (Total Current Assets 2.94b - Total Current Liabilities 1.98b) / Total Assets 7.65b |
| B: 0.26 (Retained Earnings 1.97b / Total Assets 7.65b) |
| C: 0.18 (EBIT TTM 1.30b / Avg Total Assets 7.15b) |
| D: 0.22 (Book Value of Equity 1.02b / Total Liabilities 4.65b) |
| Altman-Z'' Score: 3.11 = A |
Beneish M
-2.96
| DSRI: 1.05 (Receivables 922.0m/832.0m, Revenue 5.59b/5.28b) |
| GMI: 1.00 (GM 59.86% / 59.73%) |
| AQI: 1.00 (AQ_t 0.58 / AQ_t-1 0.57) |
| SGI: 1.06 (Revenue 5.59b / 5.28b) |
| TATA: -0.02 (NI 969.0m - CFO 1.10b) / TA 7.65b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of VLTO shares?
As of May 17, 2026, the stock is trading at USD 84.83 with a total of 2,395,524 shares traded.
Over the past week, the price has changed by -2.31%, over one month by -8.11%, over three months by -7.85% and over the past year by -15.54%.
Over the past week, the price has changed by -2.31%, over one month by -8.11%, over three months by -7.85% and over the past year by -15.54%.
Is VLTO a buy, sell or hold?
Veralto has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy VLTO.
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VLTO price?
| Analysts Target Price | 108.4 | 27.8% |
Veralto (VLTO) - Fundamental Data Overview
as of 15 May 2026
P/E Trailing = 22.1263 P/E Forward = 20.4499
P/S = 3.7698
P/B = 7.0975
P/EG = 2.5541
Revenue TTM = 5.59b USD
EBIT TTM = 1.30b USD
EBITDA TTM = 1.37b USD
Long Term Debt = 1.96b USD (from longTermDebt, last quarter)
Short Term Debt = 700.0m USD (from shortTermDebt, last quarter)
Debt = 2.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.23b USD (from netDebt column, last quarter)
Enterprise Value = 22.32b USD (21.08b + Debt 2.66b - CCE 1.43b)
Interest Coverage Ratio = 13.96 (Ebit TTM 1.30b / Interest Expense TTM 93.0m)
EV/FCF = 21.42x (Enterprise Value 22.32b / FCF TTM 1.04b)
FCF Yield = 4.67% (FCF TTM 1.04b / Enterprise Value 22.32b)
FCF Margin = 18.63% (FCF TTM 1.04b / Revenue TTM 5.59b)
Net Margin = 17.33% (Net Income TTM 969.0m / Revenue TTM 5.59b)
Gross Margin = 59.86% ((Revenue TTM 5.59b - Cost of Revenue TTM 2.25b) / Revenue TTM)
Gross Margin QoQ = 60.06% (prev 59.31%)
Tobins Q-Ratio = 2.92 (Enterprise Value 22.32b / Total Assets 7.65b)
Interest Expense / Debt = 0.90% (Interest Expense 24.0m / Debt 2.66b)
Taxrate = 20.87% (67.0m / 321.0m)
NOPAT = 1.03b (EBIT 1.30b * (1 - 20.87%))
Current Ratio = 1.48 (Total Current Assets 2.94b / Total Current Liabilities 1.98b)
Debt / Equity = 0.89 (Debt 2.66b / totalStockholderEquity, last quarter 3.00b)
Debt / EBITDA = 0.90 (Net Debt 1.23b / EBITDA 1.37b)
Debt / FCF = 1.18 (Net Debt 1.23b / FCF TTM 1.04b)
Total Stockholder Equity = 2.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.55% (Net Income 969.0m / Total Assets 7.65b)
RoE = 33.38% (Net Income TTM 969.0m / Total Stockholder Equity 2.90b)
RoCE = 26.68% (EBIT 1.30b / Capital Employed (Equity 2.90b + L.T.Debt 1.96b))
RoIC = 18.43% (NOPAT 1.03b / Invested Capital 5.57b)
WACC = 7.08% (E(21.08b)/V(23.75b) * Re(7.88%) + D(2.66b)/V(23.75b) * Rd(0.90%) * (1-Tc(0.21)))
Discount Rate = 7.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 46.67 | Cagr: 0.50%
[DCF] Terminal Value 82.47% ; FCFF base≈969.2m ; Y1≈1.01b ; Y5≈1.15b
[DCF] Fair Price = 97.32 (EV 25.13b - Net Debt 1.23b = Equity 23.90b / Shares 245.6m; r=7.08% [WACC]; 5y FCF grow 4.13% → 3.0% )
EPS Correlation: 93.48 | EPS CAGR: 9.74% | SUE: 2.44 | # QB: 3
Revenue Correlation: 95.17 | Revenue CAGR: 3.92% | SUE: 1.17 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.00 | Chg30d=-2.38% | Revisions=-73% | Analysts=13
EPS next Quarter (2026-09-30): EPS=1.07 | Chg30d=-0.07% | Revisions=+0% | Analysts=13
EPS current Year (2026-12-31): EPS=4.25 | Chg30d=+1.33% | Revisions=+76% | GrowthEPS=+9.0% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=4.64 | Chg30d=+1.87% | Revisions=+78% | GrowthEPS=+9.2% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: +78%